Skip to main content

Table 2 Tumor volume (mm3)

From: Elimination of tumor hypoxia by eribulin demonstrated by 18F-FMISO hypoxia imaging in human tumor xenograft models

 

Ex vivo study groups (n = 16)

PET imaging study groups (n = 7)

Non-treatment (n = 3)

Eribulin treatment (n = 4)

Day 1

Day 4

Day 1

Day 8

Day 1

Day 8

Control

263.0 ± 1.0

290.2 ± 34.2

241.8 ± 95.6

307.2 ± 87.3

–

–

Eribulin 0.3 mg/kg

258.8 ± 40.8

247.5 ± 39.1

–

–

285.6 ± 101.8

297.6.1 ± 113.8

Eribulin 1.0 mg/kg

250.2 ± 35.0

234.4 ± 42.9

–

–

–

–